메뉴 건너뛰기




Volumn 81, Issue 3, 2013, Pages 311-318

The role of epigenetics in malignant pleural mesothelioma

Author keywords

DNA methylation; Epigenetics; Histone acetylation; Mesothelioma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; APICIDIN; BELINOSTAT; BENZAMIDE DERIVATIVE; BUTYRIC ACID; CARBOPLATIN; CASPASE 9; CISPLATIN; DEPSIPEPTIDE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DOXORUBICIN; FLUOROURACIL; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HYDROXAMIC ACID; INTERLEUKIN 13 RECEPTOR ALPHA2; MEVINOLIN; PANOBINOSTAT; PEMETREXED; PLACEBO; PROTEIN BCL 2; RALTITREXED; UNINDEXED DRUG; UVOMORULIN; VALPROIC ACID; VORINOSTAT;

EID: 84881666987     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.05.014     Document Type: Review
Times cited : (49)

References (99)
  • 1
    • 84910467774 scopus 로고
    • Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province
    • [Epub 1960/10/01]
    • Wagner J.C., Sleggs C.A., Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960, 17:260-271. [Epub 1960/10/01].
    • (1960) Br J Ind Med , vol.17 , pp. 260-271
    • Wagner, J.C.1    Sleggs, C.A.2    Marchand, P.3
  • 2
    • 84859425794 scopus 로고    scopus 로고
    • Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma
    • [Epub 2012/02/09]
    • La Vecchia C., Boffetta P. Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma. Eur J Cancer Prev 2012, 21(3):227-230. [Epub 2012/02/09].
    • (2012) Eur J Cancer Prev , vol.21 , Issue.3 , pp. 227-230
    • La Vecchia, C.1    Boffetta, P.2
  • 3
    • 0032938943 scopus 로고    scopus 로고
    • The European mesothelioma epidemic
    • [Epub 1999/02/23]
    • Peto J., Decarli A., La Vecchia C., Levi F., Negri E. The European mesothelioma epidemic. Br J Cancer 1999, 79(3-4):666-672. [Epub 1999/02/23].
    • (1999) Br J Cancer , vol.79 , Issue.3-4 , pp. 666-672
    • Peto, J.1    Decarli, A.2    La Vecchia, C.3    Levi, F.4    Negri, E.5
  • 4
    • 19544388744 scopus 로고    scopus 로고
    • Re: "Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003"
    • [Epub 2004/10/07]
    • Lange J.H. Re: "Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003". Am J Epidemiol 2004, 160(8):823. [Epub 2004/10/07].
    • (2004) Am J Epidemiol , vol.160 , Issue.8 , pp. 823
    • Lange, J.H.1
  • 5
  • 6
    • 0347093576 scopus 로고    scopus 로고
    • Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003
    • [Epub 2004/01/14]
    • Price B., Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004, 159(2):107-112. [Epub 2004/01/14].
    • (2004) Am J Epidemiol , vol.159 , Issue.2 , pp. 107-112
    • Price, B.1    Ware, A.2
  • 7
    • 84881664353 scopus 로고    scopus 로고
    • An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma
    • [Epub 2012/03/31]
    • Pasello G., Ceresoli G.L., Favaretto A. An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma. Cancer Treat Rev 2012, [Epub 2012/03/31].
    • (2012) Cancer Treat Rev
    • Pasello, G.1    Ceresoli, G.L.2    Favaretto, A.3
  • 8
    • 0041629528 scopus 로고    scopus 로고
    • Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
    • [Epub 2003/07/16]
    • Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21(14):2636-2644. [Epub 2003/07/16].
    • (2003) J Clin Oncol , vol.21 , Issue.14 , pp. 2636-2644
    • Vogelzang, N.J.1    Rusthoven, J.J.2    Symanowski, J.3    Denham, C.4    Kaukel, E.5    Ruffie, P.6
  • 9
    • 43249105802 scopus 로고    scopus 로고
    • Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
    • [Epub 2008/04/01]
    • Jassem J., Ramlau R., Santoro A., Schuette W., Chemaissani A., Hong S., et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 2008, 26(10):1698-1704. [Epub 2008/04/01].
    • (2008) J Clin Oncol , vol.26 , Issue.10 , pp. 1698-1704
    • Jassem, J.1    Ramlau, R.2    Santoro, A.3    Schuette, W.4    Chemaissani, A.5    Hong, S.6
  • 10
    • 0035141576 scopus 로고    scopus 로고
    • Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B
    • [Epub 2001/02/13]
    • Kindler H.L., Millard F., Herndon J.E., Vogelzang N.J., Suzuki Y., Green M.R. Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. Lung Cancer 2001, 31(2-3):311-317. [Epub 2001/02/13].
    • (2001) Lung Cancer , vol.31 , Issue.2-3 , pp. 311-317
    • Kindler, H.L.1    Millard, F.2    Herndon, J.E.3    Vogelzang, N.J.4    Suzuki, Y.5    Green, M.R.6
  • 11
    • 57649088756 scopus 로고    scopus 로고
    • The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
    • [Epub 2008/05/20]
    • Stebbing J., Powles T., McPherson K., Shamash J., Wells P., Sheaff M.T., et al. The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer 2009, 63(1):94-97. [Epub 2008/05/20].
    • (2009) Lung Cancer , vol.63 , Issue.1 , pp. 94-97
    • Stebbing, J.1    Powles, T.2    McPherson, K.3    Shamash, J.4    Wells, P.5    Sheaff, M.T.6
  • 12
    • 0033564135 scopus 로고    scopus 로고
    • A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
    • [Epub 1999/06/22]
    • van Meerbeeck J.P., Baas P., Debruyne C., Groen H.J., Manegold C., Ardizzoni A., et al. A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Cancer 1999, 85(12):2577-2582. [Epub 1999/06/22].
    • (1999) Cancer , vol.85 , Issue.12 , pp. 2577-2582
    • van Meerbeeck, J.P.1    Baas, P.2    Debruyne, C.3    Groen, H.J.4    Manegold, C.5    Ardizzoni, A.6
  • 13
    • 0025716314 scopus 로고
    • DNA methylation and epigenetic inheritance
    • [Epub 1990/01/30]
    • Holliday R. DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B Biol Sci 1990, 326(1235):329-338. [Epub 1990/01/30].
    • (1990) Philos Trans R Soc Lond B Biol Sci , vol.326 , Issue.1235 , pp. 329-338
    • Holliday, R.1
  • 14
    • 0033529565 scopus 로고    scopus 로고
    • Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome
    • [Epub 1999/08/24]
    • Kornberg R.D., Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999, 98(3):285-294. [Epub 1999/08/24].
    • (1999) Cell , vol.98 , Issue.3 , pp. 285-294
    • Kornberg, R.D.1    Lorch, Y.2
  • 15
    • 1842411320 scopus 로고    scopus 로고
    • Crystal structure of the nucleosome core particle at 2.8 A resolution
    • [Epub 1997/09/26]
    • Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389(6648):251-260. [Epub 1997/09/26].
    • (1997) Nature , vol.389 , Issue.6648 , pp. 251-260
    • Luger, K.1    Mader, A.W.2    Richmond, R.K.3    Sargent, D.F.4    Richmond, T.J.5
  • 16
    • 0022540321 scopus 로고
    • CpG-rich islands and the function of DNA methylation
    • [Epub 1986/05/15]
    • Bird A.P. CpG-rich islands and the function of DNA methylation. Nature 1986, 321(6067):209-213. [Epub 1986/05/15].
    • (1986) Nature , vol.321 , Issue.6067 , pp. 209-213
    • Bird, A.P.1
  • 17
    • 0028301317 scopus 로고
    • The distribution of CpG islands in mammalian chromosomes
    • [Epub 1994/07/01]
    • Craig J.M., Bickmore W.A. The distribution of CpG islands in mammalian chromosomes. Nat Genet 1994, 7(3):376-382. [Epub 1994/07/01].
    • (1994) Nat Genet , vol.7 , Issue.3 , pp. 376-382
    • Craig, J.M.1    Bickmore, W.A.2
  • 18
    • 71749115797 scopus 로고    scopus 로고
    • Epigenetics and cancer treatment
    • [Epub 2009/10/20]
    • Kristensen L.S., Nielsen H.M., Hansen L.L. Epigenetics and cancer treatment. Eur J Pharmacol 2009, 625(1-3):131-142. [Epub 2009/10/20].
    • (2009) Eur J Pharmacol , vol.625 , Issue.1-3 , pp. 131-142
    • Kristensen, L.S.1    Nielsen, H.M.2    Hansen, L.L.3
  • 19
    • 0042132027 scopus 로고    scopus 로고
    • Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b
    • [Epub 2003/08/05]
    • Chen T., Ueda Y., Dodge J.E., Wang Z., Li E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol 2003, 23(16):5594-5605. [Epub 2003/08/05].
    • (2003) Mol Cell Biol , vol.23 , Issue.16 , pp. 5594-5605
    • Chen, T.1    Ueda, Y.2    Dodge, J.E.3    Wang, Z.4    Li, E.5
  • 20
    • 0033615717 scopus 로고    scopus 로고
    • DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
    • [Epub 1999/11/11]
    • Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99(3):247-257. [Epub 1999/11/11].
    • (1999) Cell , vol.99 , Issue.3 , pp. 247-257
    • Okano, M.1    Bell, D.W.2    Haber, D.A.3    Li, E.4
  • 21
    • 78651162036 scopus 로고
    • Acetylation and methylation of histones and their possible role in the regulation of rna synthesis
    • [Epub 1964/05/01]
    • Allfrey V.G., Faulkner R., Mirsky A.E. Acetylation and methylation of histones and their possible role in the regulation of rna synthesis. Proc Natl Acad Sci U S A 1964, 51:786-794. [Epub 1964/05/01].
    • (1964) Proc Natl Acad Sci U S A , vol.51 , pp. 786-794
    • Allfrey, V.G.1    Faulkner, R.2    Mirsky, A.E.3
  • 22
    • 0027525970 scopus 로고
    • Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA
    • [Epub 1993/01/05]
    • Hong L., Schroth G.P., Matthews H.R., Yau P., Bradbury E.M. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 1993, 268(1):305-314. [Epub 1993/01/05].
    • (1993) J Biol Chem , vol.268 , Issue.1 , pp. 305-314
    • Hong, L.1    Schroth, G.P.2    Matthews, H.R.3    Yau, P.4    Bradbury, E.M.5
  • 23
    • 0024503977 scopus 로고
    • Histone acetylation reduces nucleosome core particle linking number change
    • [Epub 1989/05/05]
    • Norton V.G., Imai B.S., Yau P., Bradbury E.M. Histone acetylation reduces nucleosome core particle linking number change. Cell 1989, 57(3):449-457. [Epub 1989/05/05].
    • (1989) Cell , vol.57 , Issue.3 , pp. 449-457
    • Norton, V.G.1    Imai, B.S.2    Yau, P.3    Bradbury, E.M.4
  • 24
    • 35649016107 scopus 로고    scopus 로고
    • Regulation of gene transcription by the histone H2A N-terminal domain
    • [Epub 2007/08/29]
    • Parra M.A., Wyrick J.J. Regulation of gene transcription by the histone H2A N-terminal domain. Mol Cell Biol 2007, 27(21):7641-7648. [Epub 2007/08/29].
    • (2007) Mol Cell Biol , vol.27 , Issue.21 , pp. 7641-7648
    • Parra, M.A.1    Wyrick, J.J.2
  • 25
    • 0013900616 scopus 로고
    • RNA synthesis and histone acetylation during the course of gene activation in lymphocytes
    • [Epub 1966/04/01]
    • Pogo B.G., Allfrey V.G., Mirsky A.E. RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc Natl Acad Sci U S A 1966, 55(4):805-812. [Epub 1966/04/01].
    • (1966) Proc Natl Acad Sci U S A , vol.55 , Issue.4 , pp. 805-812
    • Pogo, B.G.1    Allfrey, V.G.2    Mirsky, A.E.3
  • 26
    • 0017815160 scopus 로고
    • DNA associated with hyperacetylated histone is preferentially digested by DNase I
    • [Epub 1978/06/01]
    • Sealy L., Chalkley R. DNA associated with hyperacetylated histone is preferentially digested by DNase I. Nucleic Acids Res 1978, 5(6):1863-1876. [Epub 1978/06/01].
    • (1978) Nucleic Acids Res , vol.5 , Issue.6 , pp. 1863-1876
    • Sealy, L.1    Chalkley, R.2
  • 27
    • 0242348752 scopus 로고    scopus 로고
    • Histone lysine methylation: a signature for chromatin function
    • [Epub 2003/10/31]
    • Sims R.J., Nishioka K., Reinberg D. Histone lysine methylation: a signature for chromatin function. Trends Genet 2003, 19(11):629-639. [Epub 2003/10/31].
    • (2003) Trends Genet , vol.19 , Issue.11 , pp. 629-639
    • Sims, R.J.1    Nishioka, K.2    Reinberg, D.3
  • 28
    • 0036008097 scopus 로고    scopus 로고
    • Deacetylase enzymes: biological functions and the use of small-molecule inhibitors
    • [Epub 2002/02/14]
    • Grozinger C.M., Schreiber S.L. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 2002, 9(1):3-16. [Epub 2002/02/14].
    • (2002) Chem Biol , vol.9 , Issue.1 , pp. 3-16
    • Grozinger, C.M.1    Schreiber, S.L.2
  • 30
    • 0037444803 scopus 로고    scopus 로고
    • Histone deacetylases (HDACs): characterization of the classical HDAC family
    • [Epub 2002/11/14]
    • de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370(Pt 3):737-749. [Epub 2002/11/14].
    • (2003) Biochem J , vol.370 , Issue.PART 3 , pp. 737-749
    • de Ruijter, A.J.1    van Gennip, A.H.2    Caron, H.N.3    Kemp, S.4    van Kuilenburg, A.B.5
  • 31
    • 79251487813 scopus 로고    scopus 로고
    • The epigenetic landscape of addiction
    • [Epub 2011/01/29]
    • Maze I., Nestler E.J. The epigenetic landscape of addiction. Ann N Y Acad Sci 2011, 1216:99-113. [Epub 2011/01/29].
    • (2011) Ann N Y Acad Sci , vol.1216 , pp. 99-113
    • Maze, I.1    Nestler, E.J.2
  • 32
    • 40849139208 scopus 로고    scopus 로고
    • Epigenetics in cancer
    • [Epub 2008/03/14]
    • Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358(11):1148-1159. [Epub 2008/03/14].
    • (2008) N Engl J Med , vol.358 , Issue.11 , pp. 1148-1159
    • Esteller, M.1
  • 33
    • 44349131472 scopus 로고    scopus 로고
    • Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
    • [Epub 2008/05/20]
    • Kondo Y., Shen L., Cheng A.S., Ahmed S., Boumber Y., Charo C., et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008, 40(6):741-750. [Epub 2008/05/20].
    • (2008) Nat Genet , vol.40 , Issue.6 , pp. 741-750
    • Kondo, Y.1    Shen, L.2    Cheng, A.S.3    Ahmed, S.4    Boumber, Y.5    Charo, C.6
  • 34
    • 0028931408 scopus 로고
    • Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation
    • [Epub 1995/03/01]
    • Guo X.W., Th'ng J.P., Swank R.A., Anderson H.J., Tudan C., Bradbury E.M., et al. Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation. EMBO J 1995, 14(5):976-985. [Epub 1995/03/01].
    • (1995) EMBO J , vol.14 , Issue.5 , pp. 976-985
    • Guo, X.W.1    Th'ng, J.P.2    Swank, R.A.3    Anderson, H.J.4    Tudan, C.5    Bradbury, E.M.6
  • 35
    • 78049246250 scopus 로고    scopus 로고
    • Fast signals and slow marks: the dynamics of histone modifications
    • [Epub 2010/08/06]
    • Barth T.K., Imhof A. Fast signals and slow marks: the dynamics of histone modifications. Trends Biochem Sci 2010, 35(11):618-626. [Epub 2010/08/06].
    • (2010) Trends Biochem Sci , vol.35 , Issue.11 , pp. 618-626
    • Barth, T.K.1    Imhof, A.2
  • 36
    • 13844320649 scopus 로고    scopus 로고
    • Aberrant DNA methylation as a cancer-inducing mechanism
    • [Epub 2005/04/12]
    • Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005, 45:629-656. [Epub 2005/04/12].
    • (2005) Annu Rev Pharmacol Toxicol , vol.45 , pp. 629-656
    • Esteller, M.1
  • 37
    • 1042278765 scopus 로고    scopus 로고
    • The history of cancer epigenetics
    • [Epub 2004/01/21]
    • Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004, 4(2):143-153. [Epub 2004/01/21].
    • (2004) Nat Rev Cancer , vol.4 , Issue.2 , pp. 143-153
    • Feinberg, A.P.1    Tycko, B.2
  • 38
    • 79958769268 scopus 로고    scopus 로고
    • Epigenetic aberrations during oncogenesis
    • [Epub 2011/01/21]
    • Hatziapostolou M., Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 2011, 68(10):1681-1702. [Epub 2011/01/21].
    • (2011) Cell Mol Life Sci , vol.68 , Issue.10 , pp. 1681-1702
    • Hatziapostolou, M.1    Iliopoulos, D.2
  • 39
    • 77954983149 scopus 로고    scopus 로고
    • Tumor-initiating and -propagating cells: cells that we would like to identify and control
    • [Epub 2010/07/24]
    • Tysnes B.B. Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia 2010, 12(7):506-515. [Epub 2010/07/24].
    • (2010) Neoplasia , vol.12 , Issue.7 , pp. 506-515
    • Tysnes, B.B.1
  • 40
    • 0030843274 scopus 로고    scopus 로고
    • Methylation of the BRCA1 gene in sporadic breast cancer
    • [Epub 1997/08/15]
    • Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997, 57(16):3347-3350. [Epub 1997/08/15].
    • (1997) Cancer Res , vol.57 , Issue.16 , pp. 3347-3350
    • Dobrovic, A.1    Simpfendorfer, D.2
  • 41
    • 33745602221 scopus 로고    scopus 로고
    • The necessity of a human epigenome project
    • [Epub 2006/05/16]
    • Esteller M. The necessity of a human epigenome project. Carcinogenesis 2006, 27(6):1121-1125. [Epub 2006/05/16].
    • (2006) Carcinogenesis , vol.27 , Issue.6 , pp. 1121-1125
    • Esteller, M.1
  • 42
    • 0345357773 scopus 로고    scopus 로고
    • Gene silencing in cancer in association with promoter hypermethylation
    • [Epub 2003/11/25]
    • Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349(21):2042-2054. [Epub 2003/11/25].
    • (2003) N Engl J Med , vol.349 , Issue.21 , pp. 2042-2054
    • Herman, J.G.1    Baylin, S.B.2
  • 43
    • 0025891856 scopus 로고
    • Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
    • [Epub 1991/05/01]
    • Sakai T., Toguchida J., Ohtani N., Yandell D.W., Rapaport J.M., Dryja T.P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991, 48(5):880-888. [Epub 1991/05/01].
    • (1991) Am J Hum Genet , vol.48 , Issue.5 , pp. 880-888
    • Sakai, T.1    Toguchida, J.2    Ohtani, N.3    Yandell, D.W.4    Rapaport, J.M.5    Dryja, T.P.6
  • 44
    • 26444573127 scopus 로고    scopus 로고
    • Towards the human cancer epigenome: a first draft of histone modifications
    • [Epub 2005/10/06]
    • Fraga M.F., Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle 2005, 4(10):1377-1381. [Epub 2005/10/06].
    • (2005) Cell Cycle , vol.4 , Issue.10 , pp. 1377-1381
    • Fraga, M.F.1    Esteller, M.2
  • 45
    • 1842631408 scopus 로고    scopus 로고
    • Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer
    • [Epub 2004/03/26]
    • Halkidou K., Gaughan L., Cook S., Leung H.Y., Neal D.E., Robson C.N. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 2004, 59(2):177-189. [Epub 2004/03/26].
    • (2004) Prostate , vol.59 , Issue.2 , pp. 177-189
    • Halkidou, K.1    Gaughan, L.2    Cook, S.3    Leung, H.Y.4    Neal, D.E.5    Robson, C.N.6
  • 46
    • 77952853306 scopus 로고    scopus 로고
    • Histone deacetylases and epigenetic therapies of hematological malignancies
    • [Epub 2010/03/12]
    • Mercurio C., Minucci S., Pelicci P.G. Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacol Res 2010, 62(1):18-34. [Epub 2010/03/12].
    • (2010) Pharmacol Res , vol.62 , Issue.1 , pp. 18-34
    • Mercurio, C.1    Minucci, S.2    Pelicci, P.G.3
  • 47
    • 21044447215 scopus 로고    scopus 로고
    • Increased expression of histone deacetylase 2 is found in human gastric cancer
    • [Epub 2005/05/04]
    • Song J., Noh J.H., Lee J.H., Eun J.W., Ahn Y.M., Kim S.Y., et al. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005, 113(4):264-268. [Epub 2005/05/04].
    • (2005) APMIS , vol.113 , Issue.4 , pp. 264-268
    • Song, J.1    Noh, J.H.2    Lee, J.H.3    Eun, J.W.4    Ahn, Y.M.5    Kim, S.Y.6
  • 48
    • 26244441525 scopus 로고    scopus 로고
    • Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
    • [Epub 2005/09/21]
    • Zhang Z., Yamashita H., Toyama T., Sugiura H., Ando Y., Mita K., et al. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast. Breast Cancer Res Treat 2005, 94(1):11-16. [Epub 2005/09/21].
    • (2005) Breast Cancer Res Treat , vol.94 , Issue.1 , pp. 11-16
    • Zhang, Z.1    Yamashita, H.2    Toyama, T.3    Sugiura, H.4    Ando, Y.5    Mita, K.6
  • 49
    • 0023088676 scopus 로고
    • Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey
    • [Epub 1987/01/15]
    • Baris I., Simonato L., Artvinli M., Pooley F., Saracci R., Skidmore J., et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey. Int J Cancer 1987, 39(1):10-17. [Epub 1987/01/15].
    • (1987) Int J Cancer , vol.39 , Issue.1 , pp. 10-17
    • Baris, I.1    Simonato, L.2    Artvinli, M.3    Pooley, F.4    Saracci, R.5    Skidmore, J.6
  • 50
    • 0031182204 scopus 로고    scopus 로고
    • Malignant mesothelioma: current conundrums over risk estimates and whither electron microscopy for diagnosis?
    • [Epub 1997/07/01]
    • Comin C.E., de Klerk N.H., Henderson D.W. Malignant mesothelioma: current conundrums over risk estimates and whither electron microscopy for diagnosis?. Ultrastruct Pathol 1997, 21(4):315-320. [Epub 1997/07/01].
    • (1997) Ultrastruct Pathol , vol.21 , Issue.4 , pp. 315-320
    • Comin, C.E.1    de Klerk, N.H.2    Henderson, D.W.3
  • 51
    • 0347600558 scopus 로고    scopus 로고
    • Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40
    • [Epub 2003/12/12]
    • Gazdar A.F., Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 2003, 5(3):177-181. [Epub 2003/12/12].
    • (2003) Clin Lung Cancer , vol.5 , Issue.3 , pp. 177-181
    • Gazdar, A.F.1    Carbone, M.2
  • 52
    • 0025782499 scopus 로고
    • Cigarette smoking, asbestos exposure, and malignant mesothelioma
    • [Epub 1991/05/01]
    • Muscat J.E., Wynder E.L. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991, 51(9):2263-2267. [Epub 1991/05/01].
    • (1991) Cancer Res , vol.51 , Issue.9 , pp. 2263-2267
    • Muscat, J.E.1    Wynder, E.L.2
  • 53
    • 79955046310 scopus 로고    scopus 로고
    • Pathohistological diagnosis and differential diagnosis
    • [Epub 2011/04/12]
    • Tischoff I., Neid M., Neumann V., Tannapfel A. Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res 2011, 189:57-78. [Epub 2011/04/12].
    • (2011) Recent Results Cancer Res , vol.189 , pp. 57-78
    • Tischoff, I.1    Neid, M.2    Neumann, V.3    Tannapfel, A.4
  • 54
    • 0030619717 scopus 로고    scopus 로고
    • Analysis of current trends in United States mesothelioma incidence
    • [Epub 1997/02/01]
    • Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997, 145(3):211-218. [Epub 1997/02/01].
    • (1997) Am J Epidemiol , vol.145 , Issue.3 , pp. 211-218
    • Price, B.1
  • 55
    • 27244447448 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
    • [Epub 2005/09/30]
    • van Meerbeeck J.P., Gaafar R., Manegold C., Van Klaveren R.J., Van Marck E.A., Vincent M., et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005, 23(28):6881-6889. [Epub 2005/09/30].
    • (2005) J Clin Oncol , vol.23 , Issue.28 , pp. 6881-6889
    • van Meerbeeck, J.P.1    Gaafar, R.2    Manegold, C.3    Van Klaveren, R.J.4    Van Marck, E.A.5    Vincent, M.6
  • 56
    • 0037688065 scopus 로고    scopus 로고
    • Using gene expression ratios to predict outcome among patients with mesothelioma
    • [Epub 2003/04/17]
    • Gordon G.J., Jensen R.V., Hsiao L.L., Gullans S.R., Blumenstock J.E., Richards W.G., et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 2003, 95(8):598-605. [Epub 2003/04/17].
    • (2003) J Natl Cancer Inst , vol.95 , Issue.8 , pp. 598-605
    • Gordon, G.J.1    Jensen, R.V.2    Hsiao, L.L.3    Gullans, S.R.4    Blumenstock, J.E.5    Richards, W.G.6
  • 57
    • 21144456382 scopus 로고    scopus 로고
    • Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling
    • [Epub 2005/05/28]
    • Gordon G.J., Rockwell G.N., Jensen R.V., Rheinwald J.G., Glickman J.N., Aronson J.P., et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 2005, 166(6):1827-1840. [Epub 2005/05/28].
    • (2005) Am J Pathol , vol.166 , Issue.6 , pp. 1827-1840
    • Gordon, G.J.1    Rockwell, G.N.2    Jensen, R.V.3    Rheinwald, J.G.4    Glickman, J.N.5    Aronson, J.P.6
  • 58
    • 58249128191 scopus 로고    scopus 로고
    • Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome
    • [Epub 2009/01/02]
    • Christensen B.C., Houseman E.A., Godleski J.J., Marsit C.J., Longacker J.L., Roelofs C.R., et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009, 69(1):227-234. [Epub 2009/01/02].
    • (2009) Cancer Res , vol.69 , Issue.1 , pp. 227-234
    • Christensen, B.C.1    Houseman, E.A.2    Godleski, J.J.3    Marsit, C.J.4    Longacker, J.L.5    Roelofs, C.R.6
  • 59
    • 71549131914 scopus 로고    scopus 로고
    • Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma
    • [Epub 2009/11/06]
    • Goto Y., Shinjo K., Kondo Y., Shen L., Toyota M., Suzuki H., et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res 2009, 69(23):9073-9082. [Epub 2009/11/06].
    • (2009) Cancer Res , vol.69 , Issue.23 , pp. 9073-9082
    • Goto, Y.1    Shinjo, K.2    Kondo, Y.3    Shen, L.4    Toyota, M.5    Suzuki, H.6
  • 60
    • 49649127985 scopus 로고    scopus 로고
    • Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
    • [Epub 2008/03/04]
    • Christensen B.C., Godleski J.J., Marsit C.J., Houseman E.A., Lopez-Fagundo C.Y., Longacker J.L., et al. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 2008, 29(8):1555-1559. [Epub 2008/03/04].
    • (2008) Carcinogenesis , vol.29 , Issue.8 , pp. 1555-1559
    • Christensen, B.C.1    Godleski, J.J.2    Marsit, C.J.3    Houseman, E.A.4    Lopez-Fagundo, C.Y.5    Longacker, J.L.6
  • 61
    • 77954356044 scopus 로고    scopus 로고
    • Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma
    • [Epub 2010/07/03]
    • Kohno H., Amatya V.J., Takeshima Y., Kushitani K., Hattori N., Kohno N., et al. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma. Oncol Rep 2010, 24(2):423-431. [Epub 2010/07/03].
    • (2010) Oncol Rep , vol.24 , Issue.2 , pp. 423-431
    • Kohno, H.1    Amatya, V.J.2    Takeshima, Y.3    Kushitani, K.4    Hattori, N.5    Kohno, N.6
  • 62
    • 79961015580 scopus 로고    scopus 로고
    • Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma
    • [Epub 2011/06/16]
    • Kubo T., Toyooka S., Tsukuda K., Sakaguchi M., Fukazawa T., Soh J., et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011, 17(15):4965-4974. [Epub 2011/06/16].
    • (2011) Clin Cancer Res , vol.17 , Issue.15 , pp. 4965-4974
    • Kubo, T.1    Toyooka, S.2    Tsukuda, K.3    Sakaguchi, M.4    Fukazawa, T.5    Soh, J.6
  • 63
    • 70350345499 scopus 로고    scopus 로고
    • Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells
    • [Epub 2009/02/24]
    • Amatori S., Papalini F., Lazzarini R., Donati B., Bagaloni I., Rippo M.R., et al. Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. Lung Cancer 2009, 66(2):184-190. [Epub 2009/02/24].
    • (2009) Lung Cancer , vol.66 , Issue.2 , pp. 184-190
    • Amatori, S.1    Papalini, F.2    Lazzarini, R.3    Donati, B.4    Bagaloni, I.5    Rippo, M.R.6
  • 64
    • 31044451642 scopus 로고    scopus 로고
    • Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells
    • [Epub 2006/01/26]
    • Kassis E.S., Zhao M., Hong J.A., Chen G.A., Nguyen D.M., Schrump D.S. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg 2006, 131(2):298-306. [Epub 2006/01/26].
    • (2006) J Thorac Cardiovasc Surg , vol.131 , Issue.2 , pp. 298-306
    • Kassis, E.S.1    Zhao, M.2    Hong, J.A.3    Chen, G.A.4    Nguyen, D.M.5    Schrump, D.S.6
  • 65
    • 79961213442 scopus 로고    scopus 로고
    • The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma
    • [Epub 2011/07/22]
    • Nelson H.H., Almquist L.M., LaRocca J.L., Plaza S.L., Lambert-Messerlian G.M., Sugarbaker D.J., et al. The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma. Epigenetics 2011, 6(8):1029-1034. [Epub 2011/07/22].
    • (2011) Epigenetics , vol.6 , Issue.8 , pp. 1029-1034
    • Nelson, H.H.1    Almquist, L.M.2    LaRocca, J.L.3    Plaza, S.L.4    Lambert-Messerlian, G.M.5    Sugarbaker, D.J.6
  • 66
    • 84862991636 scopus 로고    scopus 로고
    • Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis
    • [Epub 2012/03/14]
    • Hollevoet K., Reitsma J.B., Creaney J., Grigoriu B.D., Robinson B.W., Scherpereel A., et al. Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 2012, 30(13):1541-1549. [Epub 2012/03/14].
    • (2012) J Clin Oncol , vol.30 , Issue.13 , pp. 1541-1549
    • Hollevoet, K.1    Reitsma, J.B.2    Creaney, J.3    Grigoriu, B.D.4    Robinson, B.W.5    Scherpereel, A.6
  • 67
    • 33846258311 scopus 로고    scopus 로고
    • Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma
    • [Epub 2006/08/09]
    • Fischer J.R., Ohnmacht U., Rieger N., Zemaitis M., Stoffregen C., Kostrzewa M., et al. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 2006, 54(1):109-116. [Epub 2006/08/09].
    • (2006) Lung Cancer , vol.54 , Issue.1 , pp. 109-116
    • Fischer, J.R.1    Ohnmacht, U.2    Rieger, N.3    Zemaitis, M.4    Stoffregen, C.5    Kostrzewa, M.6
  • 68
    • 34848873175 scopus 로고    scopus 로고
    • DNA methylation profile of 28 potential marker loci in malignant mesothelioma
    • [Epub 2007/07/31]
    • Tsou J.A., Galler J.S., Wali A., Ye W., Siegmund K.D., Groshen S., et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 2007, 58(2):220-230. [Epub 2007/07/31].
    • (2007) Lung Cancer , vol.58 , Issue.2 , pp. 220-230
    • Tsou, J.A.1    Galler, J.S.2    Wali, A.3    Ye, W.4    Siegmund, K.D.5    Groshen, S.6
  • 69
    • 77950860448 scopus 로고    scopus 로고
    • Inside HDAC with HDAC inhibitors
    • [Epub 2010/03/13]
    • Bertrand P. Inside HDAC with HDAC inhibitors. Eur J Med Chem 2010, 45(6):2095-2116. [Epub 2010/03/13].
    • (2010) Eur J Med Chem , vol.45 , Issue.6 , pp. 2095-2116
    • Bertrand, P.1
  • 70
    • 79952932076 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
    • [Epub 2011/03/19]
    • Kim H.J., Bae S.C. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 2011, 3(2):166-179. [Epub 2011/03/19].
    • (2011) Am J Transl Res , vol.3 , Issue.2 , pp. 166-179
    • Kim, H.J.1    Bae, S.C.2
  • 71
    • 0036527775 scopus 로고    scopus 로고
    • Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
    • [Epub 2002/07/18]
    • Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002, 1(4):287-299. [Epub 2002/07/18].
    • (2002) Nat Rev Drug Discov , vol.1 , Issue.4 , pp. 287-299
    • Johnstone, R.W.1
  • 72
    • 84863573728 scopus 로고    scopus 로고
    • Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells
    • [Epub 2012/05/09]
    • Catalano M.G., Fortunati N., Pugliese M., Marano F., Ortoleva L., Poli R., et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2012, [Epub 2012/05/09].
    • (2012) J Clin Endocrinol Metab
    • Catalano, M.G.1    Fortunati, N.2    Pugliese, M.3    Marano, F.4    Ortoleva, L.5    Poli, R.6
  • 73
    • 80052291991 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro
    • [Epub 2011/09/01]
    • Jin G., Bausch D., Knightly T., Liu Z., Li Y., Liu B., et al. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery 2011, 150(3):429-435. [Epub 2011/09/01].
    • (2011) Surgery , vol.150 , Issue.3 , pp. 429-435
    • Jin, G.1    Bausch, D.2    Knightly, T.3    Liu, Z.4    Li, Y.5    Liu, B.6
  • 74
    • 84859954464 scopus 로고    scopus 로고
    • Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain
    • [Epub 2012/04/24]
    • Osuka S., Takano S., Watanabe S., Ishikawa E., Yamamoto T., Matsumura A. Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain. Neurol Med Chir (Tokyo) 2012, 52(4):186-193. [Epub 2012/04/24].
    • (2012) Neurol Med Chir (Tokyo) , vol.52 , Issue.4 , pp. 186-193
    • Osuka, S.1    Takano, S.2    Watanabe, S.3    Ishikawa, E.4    Yamamoto, T.5    Matsumura, A.6
  • 75
    • 34249941680 scopus 로고    scopus 로고
    • Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
    • [Epub 2007/05/02]
    • Lindemann R.K., Newbold A., Whitecross K.F., Cluse L.A., Frew A.J., Ellis L., et al. Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A 2007, 104(19):8071-8076. [Epub 2007/05/02].
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.19 , pp. 8071-8076
    • Lindemann, R.K.1    Newbold, A.2    Whitecross, K.F.3    Cluse, L.A.4    Frew, A.J.5    Ellis, L.6
  • 76
    • 68749089762 scopus 로고    scopus 로고
    • The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
    • [Epub 2009/08/01]
    • Carlisi D., Lauricella M., D'Anneo A., Emanuele S., Angileri L., Di Fazio P., et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Eur J Cancer 2009, 45(13):2425-2438. [Epub 2009/08/01].
    • (2009) Eur J Cancer , vol.45 , Issue.13 , pp. 2425-2438
    • Carlisi, D.1    Lauricella, M.2    D'Anneo, A.3    Emanuele, S.4    Angileri, L.5    Di Fazio, P.6
  • 77
    • 0346725822 scopus 로고    scopus 로고
    • Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation
    • [Epub 2004/01/13]
    • Neuzil J., Swettenham E., Gellert N. Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation. Biochem Biophys Res Commun 2004, 314(1):186-191. [Epub 2004/01/13].
    • (2004) Biochem Biophys Res Commun , vol.314 , Issue.1 , pp. 186-191
    • Neuzil, J.1    Swettenham, E.2    Gellert, N.3
  • 78
    • 68849110181 scopus 로고    scopus 로고
    • The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
    • [Epub 2009/08/13]
    • Crisanti M.C., Wallace A.F., Kapoor V., Vandermeers F., Dowling M.L., Pereira L.P., et al. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther 2009, 8(8):2221-2231. [Epub 2009/08/13].
    • (2009) Mol Cancer Ther , vol.8 , Issue.8 , pp. 2221-2231
    • Crisanti, M.C.1    Wallace, A.F.2    Kapoor, V.3    Vandermeers, F.4    Dowling, M.L.5    Pereira, L.P.6
  • 79
    • 65649105510 scopus 로고    scopus 로고
    • A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL
    • [Epub 2009/01/31]
    • Symanowski J., Vogelzang N., Zawel L., Atadja P., Pass H., Sharma S. A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL. J Thorac Oncol 2009, 4(2):149-160. [Epub 2009/01/31].
    • (2009) J Thorac Oncol , vol.4 , Issue.2 , pp. 149-160
    • Symanowski, J.1    Vogelzang, N.2    Zawel, L.3    Atadja, P.4    Pass, H.5    Sharma, S.6
  • 80
    • 0035184066 scopus 로고    scopus 로고
    • Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma
    • [Epub 2001/11/20]
    • Cao X.X., Mohuiddin I., Ece F., McConkey D.J., Smythe W.R. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma. Am J Respir Cell Mol Biol 2001, 25(5):562-568. [Epub 2001/11/20].
    • (2001) Am J Respir Cell Mol Biol , vol.25 , Issue.5 , pp. 562-568
    • Cao, X.X.1    Mohuiddin, I.2    Ece, F.3    McConkey, D.J.4    Smythe, W.R.5
  • 81
    • 0034874520 scopus 로고    scopus 로고
    • Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma
    • [Epub 2001/09/26]
    • Mohiuddin I., Cao X., Fang B., Nishizaki M., Smythe W.R. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma. Cancer Gene Ther 2001, 8(8):547-554. [Epub 2001/09/26].
    • (2001) Cancer Gene Ther , vol.8 , Issue.8 , pp. 547-554
    • Mohiuddin, I.1    Cao, X.2    Fang, B.3    Nishizaki, M.4    Smythe, W.R.5
  • 82
    • 65249096105 scopus 로고    scopus 로고
    • Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma
    • [Epub 2009/04/09]
    • Vandermeers F., Hubert P., Delvenne P., Mascaux C., Grigoriu B., Burny A., et al. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res 2009, 15(8):2818-2828. [Epub 2009/04/09].
    • (2009) Clin Cancer Res , vol.15 , Issue.8 , pp. 2818-2828
    • Vandermeers, F.1    Hubert, P.2    Delvenne, P.3    Mascaux, C.4    Grigoriu, B.5    Burny, A.6
  • 83
    • 79959692751 scopus 로고    scopus 로고
    • Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells
    • [Epub 2011/06/16]
    • Yamauchi Y., Izumi Y., Asakura K., Fukutomi T., Serizawa A., Kawai K., et al. Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells. Biochem Biophys Res Commun 2011, 410(2):328-332. [Epub 2011/06/16].
    • (2011) Biochem Biophys Res Commun , vol.410 , Issue.2 , pp. 328-332
    • Yamauchi, Y.1    Izumi, Y.2    Asakura, K.3    Fukutomi, T.4    Serizawa, A.5    Kawai, K.6
  • 84
    • 78650201751 scopus 로고    scopus 로고
    • Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma
    • [Epub 2010/11/26]
    • Amatori S., Bagaloni I., Viti D., Fanelli M. Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. Lung Cancer 2011, 71(1):113-115. [Epub 2010/11/26].
    • (2011) Lung Cancer , vol.71 , Issue.1 , pp. 113-115
    • Amatori, S.1    Bagaloni, I.2    Viti, D.3    Fanelli, M.4
  • 85
    • 79955510603 scopus 로고    scopus 로고
    • Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts
    • [Epub 2011/03/02]
    • Takenouchi M., Hirai S., Sakuragi N., Yagita H., Hamada H., Kato K. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts. Clin Cancer Res 2011, 17(9):2819-2829. [Epub 2011/03/02].
    • (2011) Clin Cancer Res , vol.17 , Issue.9 , pp. 2819-2829
    • Takenouchi, M.1    Hirai, S.2    Sakuragi, N.3    Yagita, H.4    Hamada, H.5    Kato, K.6
  • 86
    • 84868110475 scopus 로고    scopus 로고
    • Epigallocatechin-3-gallate induces mesothelioma cell death via H(2) o(2) -dependent T-type Ca(2+) channel opening
    • [Epub 2012/05/09]
    • Ranzato E., Martinotti S., Magnelli V., Murer B., Biffo S., Mutti L., et al. Epigallocatechin-3-gallate induces mesothelioma cell death via H(2) o(2) -dependent T-type Ca(2+) channel opening. J Cell Mol Med 2012, [Epub 2012/05/09].
    • (2012) J Cell Mol Med
    • Ranzato, E.1    Martinotti, S.2    Magnelli, V.3    Murer, B.4    Biffo, S.5    Mutti, L.6
  • 87
    • 84870447823 scopus 로고    scopus 로고
    • Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis
    • [Epub 2011/05/20]
    • Wang Y., Rishi A.K., Wu W., Polin L., Sharma S., Levi E., et al. Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis. Mol Cell Biochem 2011, 357(1-2):83-94. [Epub 2011/05/20].
    • (2011) Mol Cell Biochem , vol.357 , Issue.1-2 , pp. 83-94
    • Wang, Y.1    Rishi, A.K.2    Wu, W.3    Polin, L.4    Sharma, S.5    Levi, E.6
  • 89
    • 18344396043 scopus 로고    scopus 로고
    • Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
    • [Epub 2002/04/16]
    • Sigalotti L., Coral S., Altomonte M., Natali L., Gaudino G., Cacciotti P., et al. Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer 2002, 86(6):979-982. [Epub 2002/04/16].
    • (2002) Br J Cancer , vol.86 , Issue.6 , pp. 979-982
    • Sigalotti, L.1    Coral, S.2    Altomonte, M.3    Natali, L.4    Gaudino, G.5    Cacciotti, P.6
  • 90
    • 0035126974 scopus 로고    scopus 로고
    • Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1
    • [Epub 2001/03/27]
    • Weiser T.S., Guo Z.S., Ohnmacht G.A., Parkhurst M.L., Tong-On P., Marincola F.M., et al. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J Immunother 2001, 24(2):151-161. [Epub 2001/03/27].
    • (2001) J Immunother , vol.24 , Issue.2 , pp. 151-161
    • Weiser, T.S.1    Guo, Z.S.2    Ohnmacht, G.A.3    Parkhurst, M.L.4    Tong-On, P.5    Marincola, F.M.6
  • 91
    • 80355127134 scopus 로고    scopus 로고
    • A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma
    • [Epub 2011/05/05]
    • Leclercq S., Gueugnon F., Boutin B., Guillot F., Blanquart C., Rogel A., et al. A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma. Eur Respir J 2011, 38(5):1105-1116. [Epub 2011/05/05].
    • (2011) Eur Respir J , vol.38 , Issue.5 , pp. 1105-1116
    • Leclercq, S.1    Gueugnon, F.2    Boutin, B.3    Guillot, F.4    Blanquart, C.5    Rogel, A.6
  • 92
    • 79960364764 scopus 로고    scopus 로고
    • Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth
    • [Epub 2011/05/31]
    • Guillot F., Boutin B., Blanquart C., Fonteneau J.F., Robard M., Gregoire M., et al. Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth. Vaccine 2011, 29(33):5534-5543. [Epub 2011/05/31].
    • (2011) Vaccine , vol.29 , Issue.33 , pp. 5534-5543
    • Guillot, F.1    Boutin, B.2    Blanquart, C.3    Fonteneau, J.F.4    Robard, M.5    Gregoire, M.6
  • 93
    • 84859494423 scopus 로고    scopus 로고
    • Downregulation of MUC1 expression and its recognition by CD8(+) T cells on the surface of malignant pleural mesothelioma cells treated with HDACi
    • [Epub 2011/12/07]
    • Roulois D., Blanquart C., Panterne C., Gueugnon F., Gregoire M., Fonteneau J.F. Downregulation of MUC1 expression and its recognition by CD8(+) T cells on the surface of malignant pleural mesothelioma cells treated with HDACi. Eur J Immunol 2012, 42(3):783-789. [Epub 2011/12/07].
    • (2012) Eur J Immunol , vol.42 , Issue.3 , pp. 783-789
    • Roulois, D.1    Blanquart, C.2    Panterne, C.3    Gueugnon, F.4    Gregoire, M.5    Fonteneau, J.F.6
  • 94
    • 61549123363 scopus 로고    scopus 로고
    • Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma
    • [Epub 2008/12/20]
    • Ramalingam S.S., Belani C.P., Ruel C., Frankel P., Gitlitz B., Koczywas M., et al. Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma. J Thorac Oncol 2009, 4(1):97-101. [Epub 2008/12/20].
    • (2009) J Thorac Oncol , vol.4 , Issue.1 , pp. 97-101
    • Ramalingam, S.S.1    Belani, C.P.2    Ruel, C.3    Frankel, P.4    Gitlitz, B.5    Koczywas, M.6
  • 95
    • 21244458052 scopus 로고    scopus 로고
    • Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
    • [Epub 2005/04/27]
    • Ryan Q.C., Headlee D., Acharya M., Sparreboom A., Trepel J.B., Ye J., et al. Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol 2005, 23(17):3912-3922. [Epub 2005/04/27].
    • (2005) J Clin Oncol , vol.23 , Issue.17 , pp. 3912-3922
    • Ryan, Q.C.1    Headlee, D.2    Acharya, M.3    Sparreboom, A.4    Trepel, J.B.5    Ye, J.6
  • 96
    • 33244458274 scopus 로고    scopus 로고
    • Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid
    • [Epub 2006/03/04]
    • Krug L.M., Curley T., Schwartz L., Richardson S., Marks P., Chiao J., et al. Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid. Clin Lung Cancer 2006, 7(4):257-261. [Epub 2006/03/04].
    • (2006) Clin Lung Cancer , vol.7 , Issue.4 , pp. 257-261
    • Krug, L.M.1    Curley, T.2    Schwartz, L.3    Richardson, S.4    Marks, P.5    Chiao, J.6
  • 97
    • 84871535784 scopus 로고    scopus 로고
    • Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression
    • [Epub 2013/01/10]
    • Barbone D., Cheung P., Battula S., Busacca S., Gray S.G., Longley D.B., et al. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PloS ONE 2012, 7(12):e52753. [Epub 2013/01/10].
    • (2012) PloS ONE , vol.7 , Issue.12
    • Barbone, D.1    Cheung, P.2    Battula, S.3    Busacca, S.4    Gray, S.G.5    Longley, D.B.6
  • 98
    • 69249236216 scopus 로고    scopus 로고
    • Phase I trial of vorinostat (V) in combination with pemetrexed (Pem) and cisplatin (CDDP) in patients with advanced cancer
    • NJV L.Chen, Blumenschein G., Robert F., Pluda J.M., Frankel S.R., Sharma S. Phase I trial of vorinostat (V) in combination with pemetrexed (Pem) and cisplatin (CDDP) in patients with advanced cancer. J Clin Oncol 2007, 25(18S):18088.
    • (2007) J Clin Oncol , vol.25 , Issue.18 S , pp. 18088
    • Njv, L.C.1    Blumenschein, G.2    Robert, F.3    Pluda, J.M.4    Frankel, S.R.5    Sharma, S.6
  • 99
    • 79251559363 scopus 로고    scopus 로고
    • Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study
    • [Epub 2010/06/10]
    • Scherpereel A., Berghmans T., Lafitte J.J., Colinet B., Richez M., Bonduelle Y., et al. Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J 2011, 37(1):129-135. [Epub 2010/06/10].
    • (2011) Eur Respir J , vol.37 , Issue.1 , pp. 129-135
    • Scherpereel, A.1    Berghmans, T.2    Lafitte, J.J.3    Colinet, B.4    Richez, M.5    Bonduelle, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.